Trial Profile
Open Label Pilot Efficacy and Safety Study of GLYX-13 in Subjects with Neuropathic Pain
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 01 Mar 2016
Price :
$35
*
At a glance
- Drugs Rapastinel (Primary)
- Indications Neuropathic pain
- Focus Therapeutic Use
- Sponsors Naurex
- 27 Feb 2016 Status changed from recruiting to completed, as reported by ISRCTN: Current Controlled Trials.
- 12 Feb 2015 New trial record